Drug companies defend vaccine monopolies in face of global outcry

Despite rising alarm over the immunization gap and widespread calls for greater cooperation, drug companies are hewing to the industry’s standard playbook when it comes to protecting valuable vaccine patents and manufacturing know-how.

Leave a Reply

%d bloggers like this: